- Filed
- Jan 26, 2022 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2022 · Jan 21, 2022 | 93.9M sh |
| Current Liabilities | Q3 2022 · Dec 31, 2021 | $269.04M |
| Current Liabilities | Q3 2022 · Mar 31, 2021 | $281.34M |
| Total Liabilities | Q3 2022 · Dec 31, 2021 | $1.04B |
| Total Liabilities | Q3 2022 · Mar 31, 2021 | $1.08B |
| Current Assets | Q3 2022 · Dec 31, 2021 | $574.75M |
| Current Assets | Q3 2022 · Mar 31, 2021 | $704.65M |
| Total Assets | Q3 2022 · Dec 31, 2021 | $604.29M |
| Total Assets | Q3 2022 · Mar 31, 2021 | $725.03M |
| Cash And Equivalents | Q3 2022 · Mar 31, 2021 | $674.49M |
| Cash And Equivalents | Q3 2022 · Dec 31, 2020 | $713.52M |
| Shares Diluted | Q3 2022 · Dec 31, 2020 | 90.1M sh |
| Shares Diluted | Q3 2022 · Dec 31, 2020 | 89.72M sh |
| Capex | Q3 2022 · Dec 31, 2020 | $1.04M |
| Operating Cash Flow | Q3 2022 · Dec 31, 2020 | $463.57M |
| Stockholders Equity | Q3 2022 · Dec 31, 2020 | −$270.66M |
| Stockholders Equity | Q3 2022 · Sep 30, 2020 | −$199.78M |
| Stockholders Equity | Q3 2022 · Jun 30, 2020 | −$134.61M |
| Stockholders Equity | Q3 2022 · Mar 31, 2020 | −$108.28M |
| Eps Diluted | Q3 2022 · Dec 31, 2020 | −$0.82 |
| Eps Diluted | Q3 2022 · Dec 31, 2020 | −$1.94 |
| Eps Basic | Q3 2022 · Dec 31, 2020 | −$0.82 |
| Eps Basic | Q3 2022 · Dec 31, 2020 | −$1.94 |
| Sga Expense | Q3 2022 · Dec 31, 2020 | $49.24M |
| Sga Expense | Q3 2022 · Dec 31, 2020 | $103.39M |
| Rd Expense | Q3 2022 · Dec 31, 2020 | $30.45M |
| Rd Expense | Q3 2022 · Dec 31, 2020 | $115.16M |
| Net Income | Q3 2022 · Dec 31, 2020 | −$73.85M |
| Net Income | Q3 2022 · Dec 31, 2020 | −$173.77M |
| Net Income | Q3 2022 · Sep 30, 2020 | −$67.06M |
| Net Income | Q3 2022 · Jun 30, 2020 | −$32.86M |
| Operating Income | Q3 2022 · Dec 31, 2020 | −$78.32M |
| Operating Income | Q3 2022 · Dec 31, 2020 | −$183.84M |